Pharma Intelligence is part of the Business Intelligence Division of Informa PLC
TThis is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
We are living in unprecedented times. Since the outbreak of COVID-19, there has been disruption to clinical trial management. Patient non-attendance for assessments, laboratory tests not being submitted and site closures all pose risks to the integrity of trial data and it is expected that these challenges will impact trials for at least four to five months.
Sponsors are both ethically and economically obliged to continue ongoing trials, and ensuring that decisions around protocol revisions and other trial adjustments are properly captured and documented is essential to the scientific integrity of the trial.
In this webinar, industry experts will present regulatory and operational insights to enable you to be proactive now to protect patient safety and minimize disruption.
Executive Vice President, Scientific Operations, Clinical Research Services, ICON plc.
Andrew Garrett is responsible for strategic direction and operational execution of ICON’s Global Scientific Operations. He was Chair and founder of the Royal Statistical Society’s Data Science Section having previously been VP/Honorary Secretary of the RSS, and Chair of its Long Term Strategy Group. He was previously a Board member of the UK’s Administrative Data Research Network and is currently a member of UKSA’s Research Accreditation Panel that oversees the approval of research projects in accordance with the Digital Economy Act 2018. Andy has a BSc in Economics, an MSc in Medical Statistics and a PhD in Applied Statistics. He has worked extensively in the area of rare diseases and has a portfolio of published papers on the topics of non-inferiority trials, subgroup analysis, data transparency and modelling and simulation.
Senior Vice President, Clinical Operations, Clinical Research Services, ICON plc.
Editor, Custom Content
Informa Pharma Intelligence